Ignite Creation Date:
2024-05-06 @ 7:46 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06126796
Status:
RECRUITING
Last Update Posted:
2024-05-16
First Post:
2023-11-07
Brief Title:
Urine-based Molecular Testing vs Cystoscopy for Surveillance of Nonmuscle Invasive Bladder Cancer NMIBC
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Study Overview
Official Title:
A Randomized Cross-Over Study to Evaluate Patient Preference and Satisfaction With Urine-based Molecular Testing Versus Cystoscopy for Surveillance of Nonmuscle Invasive Bladder Cancer NMIBC
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate patient-reported preference for urine based molecular testing CxBladder Monitor compared to cystoscopy for patients on surveillance for Nonmuscle Invasive Bladder Cancer NMIBC Urine based molecular testing involves noninvasive testing of a urine sample for biomarkers associated with disease recurrence Cystoscopy is an examination of the bladder and urethra using a thin tube like instrument that is inserted into the urethra
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 23-008567 | OTHER | None | None |
| NCI-2023-09278 | REGISTRY | Clinical Trials Reporting Program CTRP | None |